Target intelligence / Profile preview

Polypyrimidine tract-binding protein 1 (PTBP1)

Target
PTBP1
Molecular classification
RNA-binding protein, Heterogeneous nuclear ribonucleoprotein (hnRNP) family, Other
01

Overview

Polypyrimidine tract-binding protein 1 (PTBP1) is a modular RNA-binding protein composed of four RNA recognition motifs (RRMs), structurally classified as a heterogeneous nuclear ribonucleoprotein (hnRNP)[7][4][3]. PTBP1 binds preferentially to polypyrimidine tracts in pre-mRNA introns, where it regulates multiple steps of RNA maturation, including alternative splicing, polyadenylation, mRNA localization, stability, and translation (notably internal ribosome entry site, IRES-mediated translation)[6][4][7][1]. In the nucleus, PTBP1 acts primarily as a splicing repressor by binding to polypyrimidine-rich sequences near splice junctions[7][6], but can both repress and activate splicing in a context-dependent manner by modulating exon definition[2]. PTBP1 additionally serves as an RNA chaperone, remodeling secondary RNA structures to control translation initiation and the fate of specific mRNAs[2][1]. Beyond splicing, it modulates microRNA function and acts as a key regulator of neuronal development—suppression of PTBP1 expression by miR-124 promotes neuronal differentiation[2]. In cancer, overexpression of PTBP1 drives aberrant splicing patterns that favor tumor progression, metabolic reprogramming (such as promoting the PKM2 isoform), and chemoresistance; it is thus studied as a biomarker and potential cancer therapeutic target[2]. PTBP1’s dysregulation is also implicated in viral infection (by facilitating cap-independent translation of viral RNA)[1] and potentially in neurodegenerative disease[2]. PTBP1's interaction with cellular proteins, such as the prosurvival protein MCL1, reveals an additional regulatory axis through which its splicing and translational effects may be modulated[4]. No small-molecule drugs directly targeting PTBP1 are currently approved; its broad role in RNA processing presents both opportunities and challenges for safe therapeutic targeting due to its potential widespread effects on gene expression[2][4].

Other names
Polypyrimidine tract-binding protein 1PTBP1PTBhnRNP IHNRNPIHeterogeneous nuclear ribonucleoprotein IPTB2PTB3PTB4pPTB57 kDa RNA-binding protein PPTB-1heterogeneous nuclear ribonucleoprotein polypeptide I
02

Mechanism of action

Modulate alternative splicing; Inhibit/enhance translation via RNA structural modulation

03

Biological functions

Alternative splicing regulationRegulation of mRNA stability and localizationTranslational regulation (IRES-dependent)RNA chaperone activityPolyadenylation regulationMicroRNA function modulation
04

Disease associations

CancerNeurological/neurodevelopmental diseasesInfection (viral translation)Other
05

Safety considerations

Potential for broad transcriptome-wide effects via splicing modulationOncogenic risk with long-term modulation
06

Biomarkers

Overexpression in various cancersExpression levels for neuronal differentiation (e.g., miR-124-mediated repression as a marker)

Beyond the preview

Go deeper on Polypyrimidine tract-binding protein 1 (PTBP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polypyrimidine tract-binding protein 1 (PTBP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call